60 minutes
Innovative treatments like a curative gene therapy are creating unprecedented access issues. How can we better communicate a breakthrough therapy’s value to payers and patient communities alike to secure access? What happens when the value of a therapy is indisputable but society still debates its costs? While the gift of health is priceless for sick patients, it’s clear that not everyone agrees that it’s worth the cost.
